Advancing Safer, Needle-Free Treatments for Retinal Diseases
Revolutionising Retinal Therapy with a Safer, Non-Invasive Gene Delivery Approach
The Future of Eye Care
Our research combines a gentle nasal spray that delivers medication directly to the retina with a novel, non-viral peptide technology to transport genetic therapies inside cells. This provides an effective, less invasive option to improve safety, reduce discomfort, and simplify care for patients.
NON-INVASIVE
Retinal Therapy Breakthrough Without Needles
Intranasal Delivery
Improving Vision, Comfort, and Care with a Safer, Simpler Solution
Our formulation offers a safe, needle-free alternative to eye injections by delivering therapies directly to the retina through a nasal spray. Paired with our non-viral peptide technology for intracellular drug delivery, we aim to help improve patient outcomes while reducing discomfort, lowering risks, and simplifying retinal care.
Non-Invasive Delivery
Needle-free nasal spray bypasses injections, delivering treatments directly to the retina.
Non-Viral Peptides
Efficiently transports genetic therapies into cells without the safety risks of viral vectors.
Patient Comfort:
Reduces discomfort, anxiety, and risk of complications compared to traditional injections.
Targeted Therapy:
Enables precise, localised treatment of retinal diseases to maximise efficacy.
Simplified Care:
Designed for easy administration and better adherence, lowering the burden on patients and healthcare providers.
Engaging Innovators, Caregivers, and Patients in Retinal Health
Partnering Across the Ecosystem to Transform Eye Disease Treatment
Patients with retinal diseases
Including diabetic retinopathy, macular degeneration, and inherited disorders, primarily adults 50+, but also younger individuals with genetic conditions.
Ophthalmologists and retinal specialists
Seeking safer, less invasive treatments that enhance patient comfort and adherence.
Healthcare providers and clinic staff
Aiming to simplify retinal care and reduce risks in therapy administration.
Pharma and biotech companies
Developing retinal or gene-based therapies in need of targeted, non-viral delivery platforms.
Help Shape the Future of Retinal Treatment
Your experience and insights matter. We’re developing a safer, simpler alternative to eye injections, and your input can guide our research.
By taking our short survey, you’ll help us better understand patient needs, clinical challenges, and what matters most in treatment innovation.
Take the survey today and be part of shaping tomorrow’s care.
Connect with Our Team
Contact Us
Are you interested in partnering, learning more, or exploring how our technology can support your work? Get in touch, we’d love to connect.